Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2
- 31 May 2007
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 170 (5), 1573-1584
- https://doi.org/10.2353/ajpath.2007.060850
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancerBritish Journal of Cancer, 2006
- Tenascin C and annexin II expression in the process of pancreatic carcinogenesisThe Journal of Pathology, 2006
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2005
- KLF11 mediates a critical mechanism in TGF-β signaling that is inactivated by Erk-MAPK in pancreatic cancer cellsGastroenterology, 2004
- Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular MotilityPublished by Elsevier BV ,1998
- The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitroOncogene, 1998
- Isolation of tissue‐type plasminogen activator, cathepsin H, and non‐specific cross‐reacting antigen from SK‐PC‐1 pancreas cancer cells using subtractive hybridizationFEBS Letters, 1996
- Annexin II tetramer: structure and functionMolecular and Cellular Biochemistry, 1995
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.JCI Insight, 1992
- The epidermal growth factor receptor in human pancreatic cancerThe Journal of Pathology, 1992